Skip to main content
Premium Trial:

Request an Annual Quote

As Expected, Nasdaq Delists Tripos From Global Market; Will Now Look to OTC

NEW YORK (GenomeWeb News) — The Nasdaq Global Market has delisted Tripos’ common stock as of this morning, Tripos said today.
 
Tripos said the exchange notified the company on Tuesday it would be removed from the exchange for non-compliance with market rules concerning minimum market capitalization and shareholder’s equity.
 
Tripos said the delisting was expected due to the recent sale of its Discovery Research business, after which it had become a “public shell” and was no longer eligible for listing on the Nasdaq Global Market.
 
The company said it plans to ask for bids on the Over-the-Counter Bulletin Board, and that its stock will be available for quotation on the Pink Sheets electronic quotation service.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.